Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the... Ann Surg Oncol (2017) 24:2539–2546 DOI 10.1245/s10434-017-5863-x OR IG INA L A R TIC L E – BREA S T O NC OLOG Y Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) 1 2 2 3 4 Peter Beitsch, MD , Pat Whitworth, MD , Paul Baron, MD , Michael C. Rotkis, MD , Angela M. Mislowsky, MD , 5 6 7 8 Paul D. Richards, MD , Mary K. Murray, MD , James V. Pellicane, MD , Carrie L. Dul, MD , Charles H. Nash, 9 10 10 11 12 MD , Lisette Stork-Sloots, MSc , Femke de Snoo, MD, PhD , Sarah Untch, BS , and Laura A. Lee, MD 1 2 Targeted Medical Education, Dallas Breast Center, Dallas, TX; Targeted Medical Education, Nashville Breast Center, 3 4 Nashville, TN; Breast & Melanoma Specialists of Charleston, Charleston, SC; Northern Indiana Cancer Research 5 6 Consortium, South Bend, IN; Coastal Carolina Breast Center, Murrells Inlet, SC; Blue Ridge Cancer Care, Roanoke, VA; 7 8 9 Cleveland Clinic Akron General, Akron, OH; Virginia Breast Center, Bon Secours Cancer Institute, Richmond, VA; St. 10 11 John Region, Grosse Pointe Woods, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

Loading next page...
 
/lp/springer_journal/pertuzumab-trastuzumab-ct-versus-trastuzumab-ct-therapy-for-her2-qu6SVdcd2H
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery
ISSN
1068-9265
eISSN
1534-4681
D.O.I.
10.1245/s10434-017-5863-x
Publisher site
See Article on Publisher Site

Abstract

Ann Surg Oncol (2017) 24:2539–2546 DOI 10.1245/s10434-017-5863-x OR IG INA L A R TIC L E – BREA S T O NC OLOG Y Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) 1 2 2 3 4 Peter Beitsch, MD , Pat Whitworth, MD , Paul Baron, MD , Michael C. Rotkis, MD , Angela M. Mislowsky, MD , 5 6 7 8 Paul D. Richards, MD , Mary K. Murray, MD , James V. Pellicane, MD , Carrie L. Dul, MD , Charles H. Nash, 9 10 10 11 12 MD , Lisette Stork-Sloots, MSc , Femke de Snoo, MD, PhD , Sarah Untch, BS , and Laura A. Lee, MD 1 2 Targeted Medical Education, Dallas Breast Center, Dallas, TX; Targeted Medical Education, Nashville Breast Center, 3 4 Nashville, TN; Breast & Melanoma Specialists of Charleston, Charleston, SC; Northern Indiana Cancer Research 5 6 Consortium, South Bend, IN; Coastal Carolina Breast Center, Murrells Inlet, SC; Blue Ridge Cancer Care, Roanoke, VA; 7 8 9 Cleveland Clinic Akron General, Akron, OH; Virginia Breast Center, Bon Secours Cancer Institute, Richmond, VA; St. 10 11 John Region, Grosse Pointe Woods,

Journal

Annals of Surgical OncologySpringer Journals

Published: Apr 26, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off